Grey Healthcare Group Acquires MIT, a Leading Japanese Advertising and Medical Education Company
Expands Grey Healthcare Group's Global Network of Medical Education Companies
Mr Umezu founded the company in 1992, turning it into one of Japan's most respected agencies. It currently offers a full range of marketing and educational programs, and has expertise in numerous therapeutic categories including psychiatry, gastroenterology, ophthalmology, infectious disease, cardiology, HIV, dermatology, neurology, allergy, and immunology.
Some of GHG Japan's educational programs include single-sponsored journals, original and translated textbook and reference books, patient educational programs, promotional programs (training manuals, pamphlets, monographs, slides and CD-ROMs), and meetings and symposia materials inviting top researchers and thought leaders from the US and Europe, and secretariats of medical associations.
"Hisa has a great understanding of the local and global marketplace, and we are very pleased to have a company like this join our network," says Lynn O'Connor Vos, CEO of GHG Worldwide. "Grey Healthcare has an excellent collection of global advertising and medical education companies, and GHG Japan, with its reputation and cultural insights, is a very strong addition to our offerings."
GHG Japan is fully integrated with GHG's advertising and medical education companies, including GHG Advertising, Avenue Grey, GHG London, Germany, and France, Phase Five Communications, International Meeting and Science, Insight Medical Communications, and CME Institute.
Headquartered in New York, GHG comprises 10 companies with 42 offices in 16 countries. It provides an extensive array of integrated services in support of brand acceleration and sales, including branding, advertising, CME and medical education, direct-to-consumer/direct-to-patient communications, managed markets, e-marketing, consumer healthcare research, and contract sales.
GHG is a wholly-owned partner company of GGG , the world's seventh largest holding agency.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.